ALX Oncology
ALX Oncology is a California-based biotechnology company that researches and develops immuno-oncology therapies for the treatment of cancer.
Business Model:
Revenue: $1.2M
Employees: 11-50
Industries / Tags:
Detailed ALX Oncology Information
Geographic Data
Address: 323 Allerton Avenue
City: San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
initial coin offering
Raised Last:
$0
Raised Total:$166M
Social
Metrics
6,477,206Website Global Rank
871Website Monthly Traffic
Twitter Followers
Description
ALX Oncology is a California-based biotechnology company that researches and develops immuno-oncology therapies for the treatment of cancer.
Contact Phone:
+16504667125
Contact Email:
ALX Oncology went public on 7/16/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/16/2020
IPO Valuation:
$669M
Ticker Symbol:
ALXO
IPO Price:
$19/share
Amount Raised:
$162M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Post-IPO Debt | $100M |
Oxford Finance LLC Silicon Valley Bank |
3/2017 | Convertible Note | 2 | $25M |
Lightstone Ventures Lightstone Ventures venBio Partners Lightstone Ventures Lightstone Ventures venBio Partners |
10/2022 | Post-IPO Debt | 2 | $100M |
Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC |
7/2020 | Initial Coin Offering | - | 12/2020 | Post-IPO Equity | $208M | 7/2020 | IPO | $169.4M |
|
2/2020 | Series C | 9 | $105M |
Cormorant Asset Management venBio Partners Logos Capital Vivo Capital Lightstone Ventures Foresite Capital BVF Partners Janus Henderson Investors HBM Healthcare Investments AG Vivo Capital Cormorant Asset Management venBio Partners Logos Capital Vivo Capital Lightstone Ventures Foresite Capital BVF Partners Janus Henderson Investors HBM Healthcare Investments AG Vivo Capital |
3/2015 | Series A | 3 | $36M |
venBio Partners The Longevity Fund Lightstone Ventures venBio Partners |
7/2020 | Initial Coin Offering | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 10/2021 | ScalmiBio |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
